Chemotype 3

Chemotype 3 refers to cannabis plants expressing a cannabinoid profile dominated by cannabichromene (CBC) as a primary minor cannabinoid, alongside THC and/or CBD in variable ratios. This chemotype classification emerged from phytochemical research distinguishing plants by their dominant secondary cannabinoids rather than THC/CBD alone. Chemotype 3 genetics are less common in commercial breeding compared to high-THC or CBD-dominant lines, though interest in minor cannabinoids has expanded breeding efforts in this category. Lineage records frequently report Chemotype 3 expressions in certain landrace and hybrid populations, particularly those with Southeast Asian or African heritage. Breeders working to stabilize CBC-forward genetics face challenges in consistency, as minor cannabinoid expression varies with cultivation conditions and plant maturity.

Breeders pursuing minor cannabinoid diversity use Chemotype 3 genetics as breeding stock to explore cannabinoid ratios beyond conventional THC/CBD frameworks. Stabilizing and selecting for CBC expression requires multi-generational crossing and phytochemical testing to maintain chemotype consistency across offspring.